Sign in
Taking people in DenmarkPhase 1

JFI447 Compared With FFG233 on Scans in People With Several Types of Solid Tumors

Tests JFI447 and how it shows on scans in adults with solid tumors.

Key facts

Who runs it
Novartis Pharma AG
Where
Copenhagen Oe and Odense C, DenmarkSee the 2 sites
Registry title
A clinical trial to learn about the effects of JFI447 and how it shows up in scans compared to FFG233 in people with solid tumors
Status
Recruiting
Phase
Phase 1
People taking part
22 people, planned
Started
22 Sept 2026
Expected to end
15 Nov 2027
Type of study
Interventional
Record updated
10 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with certain metastatic solid tumors. It compares how JFI447 and FFG233 show up in scans.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Metastatic cancer: pancreatic ductal cancer (PDAC), non-small cell lung cancer (NSCLC), HR+/HER2- ductal and lobular breast cancer, triple-negative breast cancer (TNBC), colorectal cancer (CRC) or soft tissue sarcoma (STS).

Main reasons for not taking part

  • Healthy volunteers cannot join.

Where in Denmark

  • RigshospitaletCopenhagen Oe, DenmarkTaking people
  • Odense University HospitalOdense C, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
JFI447 Compared With FFG233 on Scans in People With Several Types of Solid TumorsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
10 June 2026